U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

Buying a new pharmacy will allow Hims & Hers to expand into new markets. Hims & Hers ( HIMS -1.11%) recently acquired a ...

Volatility continues for Hims & Hers. While this week was good for the stock, shares of Hims & Hers have been all over the ...

Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...

Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...

Last week’s 19% gain means that institutional investors were on the positive end of the spectrum even as the company has ...

Hims & Hers Health's HIMS short percent of float has risen 22.07% since its last report. The company recently reported that ...

Sound familiar? So here are some items of interest. Have a great day, everyone. … Hims & Hers Health plans to sell compounded versions of Novo Nordisk’s popular weight loss drug Wegovy to patients in ...

Whether you're cycling the streets or on a stationary bike, cycling is great aerobic exercise. Not all research agrees, but ...